HYPERTONIC SALINE IN ACUTE VIRAL BRONCHIOLITIS: A RANDOMIZED CLINICAL TRIAL
Status:
Withdrawn
Trial end date:
2014-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether nebulized hypertonic saline solution
reduces the admission rate 48 hours after initial treatment in the emergency department, when
compared to normal saline solution (placebo). We hypothesise that patients with bronchiolitis
who receive nebulized hypertonic saline solution will have less respiratory distress, less
duration of symptoms and therefore less risk of being hospitalized than those receiving
normal saline solution.
Phase:
N/A
Details
Lead Sponsor:
Laval University
Collaborators:
Canadian Institutes of Health Research (CIHR) Centre de Recheche du Centre Hospitalier Université Laval